Deadline: 28-Apr-2026
The Cost-Disrupting Innovations Grand Challenge seeks transformative solutions to lower the cost of Ready-to-Use Therapeutic Food (RUTF) for treating Severe Acute Malnutrition (SAM). Funding up to $1.5 million USD supports innovations in protein, lipid, packaging, production, and supply to achieve at least a 30% reduction in ex-factory costs while maintaining clinical safety and nutritional adequacy. The initiative emphasizes scalable, cost-effective solutions for low- and middle-income countries (LMICs).
Overview of the Grand Challenge
The Cost-Disrupting Innovations Grand Challenge aims to transform RUTF production by significantly reducing costs while ensuring safe, nutritionally adequate therapeutic foods. By improving affordability, the initiative seeks to expand access to treatment for children suffering from SAM in resource-constrained settings. The program emphasizes measurable, scalable innovations with clear pathways to regulatory acceptance and real-world impact.
Key Focus Areas
The initiative targets four primary areas for innovation:
- Protein Diversification and Dairy Replacement: Reduce reliance on milk powder while maintaining high protein quality and nutrient adequacy.
- Lipid Optimization and Stabilization: Enable use of lower-cost, locally available oils without compromising shelf life or nutrition.
- Packaging Materials Science: Lower packaging costs while improving sustainability and durability.
- Production and Supply Innovations: Enhance manufacturing efficiency, reduce operational costs, and improve scalability in LMIC contexts.
Objectives and Expected Outcomes
- Achieve at least 30% reduction in ex-factory RUTF costs.
- Support scalable and sustainable production to treat more children with SAM within existing budgets.
- Ensure clinical safety and nutritional adequacy in line with Codex RUTF Guidelines.
- Promote equitable access and responsible intellectual property practices in low-income markets.
Funding Options
- Option A: Up to $500,000 USD, grant term of up to 18 months.
- Option B: Up to $1,500,000 USD, grant term of up to 36 months.
- Budget Guidelines: Indirect costs should not exceed 10–15% of the total award. Budgets must reflect scope, ambition, and scalability of the proposed work.
Eligibility Criteria
Eligible applicants include:
- Research institutions, manufacturers, technology firms, NGOs, and private sector entities.
- Preference for collaborations involving LMIC-based partners.
- Applicants must demonstrate proof-of-concept feasibility through pilot manufacturing, simulations, or engineering models.
- Proposals must outline a credible regulatory pathway and demonstrate scalable cost reductions.
Proposal Requirements
Applicants should:
- Propose innovations affecting ingredients, formulation, manufacturing, packaging, or factory-level economics.
- Include transparent cost models, assumptions, and sensitivity analyses.
- Maintain nutritional adequacy, protein quality, and energy density per Codex RUTF Guidelines.
- Demonstrate clinical noninferiority for any formulation changes.
- Present a strategy for scaling production while maintaining cost efficiency.
- Ensure innovations are suitable for low- and middle-income country settings.
Why This Grand Challenge Matters
- Expands treatment access: Lower RUTF costs enable more children to receive treatment.
- Encourages innovation: Promotes novel approaches to protein, lipid, packaging, and manufacturing.
- Supports LMIC manufacturing: Strengthens regional production capacity and sustainability.
- Ensures safety and efficacy: Maintains nutritional standards and clinical acceptability.
- Promotes equitable access: Encourages responsible IP and data transparency practices.
How to Apply
- Develop Proposal
- Include problem statement, targeted cost reductions, technical approach, and anticipated impact.
- Provide detailed budget, assumptions, and cost models.
- Demonstrate Feasibility
- Include pilot production, simulations, or engineering models.
- Show compliance with Codex RUTF Guidelines and clinical safety.
- Plan for Scale
- Outline pathways to regulatory acceptance, manufacturing scale-up, and sustainability.
- Include strategies for LMIC implementation and equitable access.
- Submit Proposal
- Ensure compliance with funding limits, indirect cost caps, and collaboration expectations.
Common Mistakes to Avoid
- Proposing solutions that compromise nutritional adequacy or clinical safety.
- Ignoring Codex RUTF Guidelines for energy, protein, or lipid standards.
- Failing to provide transparent cost models or scalability plans.
- Omitting proof-of-concept evidence such as pilot manufacturing or simulations.
- Submitting proposals without LMIC applicability or responsible IP considerations.
Frequently Asked Questions (FAQ)
1. What is the funding range for the challenge?
Option A: Up to $500,000 USD, Option B: Up to $1,500,000 USD.
2. Who is eligible to apply?
Research institutions, manufacturers, technology firms, NGOs, and private sector entities, preferably with LMIC partnerships.
3. What are the focus areas?
Protein diversification, lipid optimization, packaging science, and production/supply innovations.
4. Are pilot or proof-of-concept projects accepted?
Yes, all stages including early-stage proof-of-concept are encouraged.
5. What standards must RUTF meet?
All RUTF must comply with Codex Guidelines, including energy density, protein/lipid composition, and protein quality.
6. Is scalability required?
Yes. Proposals must demonstrate a pathway to scalable, cost-effective production.
7. Are there restrictions on IP and licensing?
Applicants are encouraged to implement responsible IP practices with affordable licensing in low-income markets.
Conclusion
The Cost-Disrupting Innovations Grand Challenge seeks transformative solutions to reduce RUTF costs while maintaining safety, nutrition, and scalability. By addressing ingredient, manufacturing, packaging, and supply challenges, this initiative aims to expand access to SAM treatment, strengthen LMIC manufacturing, and improve global child nutrition outcomes.
For more information, visit Gates Foundation.